Parallax Volatility Advisers
AIMT

Parallax Volatility Advisers’s Aimmune Therapeutics AIMT Stock Holding History

Parallax Volatility Advisers’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,000
Closed -$546K – 4342
2018
Q3 		$546K Hold
20,000
– – ﹤0.01% 1416
2018
Q2 		$538K Buy
+20,000
New +$612K ﹤0.01% 1254

Parallax Volatility Advisers's AIMT Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 8,442 shares — an estimated $291K sold.

Parallax Volatility Advisers first reported a position in AIMT in Q4 2017 and held it in 6 quarters. The position peaked at $755K in Q4 2019. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 8,442 Aimmune Therapeutics shares in Q4 2020, an estimated $291K.
  • Parallax Volatility Advisers first reported a position in Aimmune Therapeutics in Q4 2017 and held it in 6 quarters.
  • Parallax Volatility Advisers's Aimmune Therapeutics position peaked at $755K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.